Search Results - "Marchionni, Niccolo"

Refine Results
  1. 1
  2. 2

    Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients by Mannucci, Edoardo, Monami, Matteo, Balzi, Daniela, Cresci, Barbara, Pala, Laura, Melani, Cecilia, Lamanna, Caterina, Bracali, Ilaria, Bigiarini, Michela, Barchielli, Alessandro, Marchionni, Niccolo, Rotella, Carlo Maria

    Published in Diabetes care (01-09-2010)
    “…OBJECTIVE: Recent epidemiological studies suggested that some insulin analogues could be associated with increased risk of cancer. The present study is aimed…”
    Get full text
    Journal Article
  3. 3
  4. 4

    A multidisciplinary case report of multiple myeloma with renal and cardiac involvement: a look beyond amyloidosis by Innocenti, Samantha, Bacchi, Beatrice, Allinovi, Marco, Perfetto, Federico, Antonioli, Elisabetta, Marchionni, Niccolo, Di Mario, Carlo, Caroti, Leonardo, Cappelli, Francesco, Stefàno, Pierluigi

    Published in BMC nephrology (17-11-2022)
    “…Background Multiple myeloma (MM) is a malignant neoplasm associated with kidney involvement in nearly half of the patients. Cast nephropathy, monoclonal…”
    Get full text
    Journal Article
  5. 5

    Antihypertensive Medications and Differences in Muscle Mass in Older Persons: The Health, Aging and Body Composition Study by Di Bari, Mauro, Van De Poll-Franse, Lonneke V., Onder, Graziano, Kritchevsky, Stephen B., Newman, Anne, Harris, Tamara B., Williamson, Jeff D., Marchionni, Niccoló, Pahor, Marco

    “…Objectives: To evaluate whether older persons using angiotensin‐converting enzyme (ACE) inhibitors have a larger lower extremity muscle mass (LEMM) than users…”
    Get full text
    Journal Article
  6. 6
  7. 7

    β-blockers: Their new life from hypertension to cancer and migraine by Fumagalli, Carlo, Maurizi, Niccolò, Marchionni, Niccolò, Fornasari, Diego

    Published in Pharmacological research (01-01-2020)
    “…[Display omitted] The pharmacological class of β-blockers includes a plea of molecules with largely different pharmacokinetic and pharmacodynamic…”
    Get full text
    Journal Article
  8. 8

    Practical use of Direct Oral Anti Coagulants (DOACs) in the older persons with atrial fibrillation by Bo, Mario, Marchionni, Niccolò

    Published in European journal of internal medicine (01-01-2020)
    “…Direct Oral Anticoagulants (DOACs) consistently demonstrated a greater net clinical benefit compared to Vitamin K Antagonists (VKAs) also in persons aged 75…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials by Monami, Matteo, Marchionni, Niccolò, Mannucci, Edoardo

    Published in European journal of endocrinology (01-06-2009)
    “…ObjectiveThe role of glucagon-like peptide-1 (GLP-1) receptor agonists in the treatment of type 2 diabetes is debated; many recent trials, which were not…”
    Get full text
    Journal Article
  11. 11

    Propranolol for Off-label Treatment of Patients With Melanoma: Results From a Cohort Study by De Giorgi, Vincenzo, Grazzini, Marta, Benemei, Silvia, Marchionni, Niccolò, Botteri, Edoardo, Pennacchioli, Elisabetta, Geppetti, Pierangelo, Gandini, Sara

    Published in JAMA oncology (08-02-2018)
    “…Preclinical and retrospective studies showed that β-blockers inhibit angiogenesis and disrupt migration of melanoma cells via inhibition of…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14

    Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis by Monami, Matteo, Marchionni, Niccolò, Mannucci, Edoardo

    Published in Diabetes research and clinical practice (01-08-2008)
    “…Long-acting insulin analogues, in comparison with NPH insulin, should warrant a greater reproducibility of absorption after subcutaneous injection, providing…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Predictors of physical frailty improvement in older patients enrolled in a multidisciplinary cardiac rehabilitation program by Baldasseroni, Samuele, Silverii, Maria Vittoria, Herbst, Andrea, Orso, Francesco, Di Bari, Mauro, Pratesi, Alessandra, Burgisser, Costanza, Ungar, Andrea, Marchionni, Niccolò, Fattirolli, Francesco

    Published in Heart and vessels (01-08-2023)
    “…Cardiac rehabilitation (CR) improves clinical and functional recovery in older patients after acute cardiac syndromes, whose outcome is influenced by cardiac…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Comparing the prognostic accuracy for all-cause mortality of frailty instruments: a multicentre 1-year follow-up in hospitalized older patients by Pilotto, Alberto, Rengo, Franco, Marchionni, Niccolò, Sancarlo, Daniele, Fontana, Andrea, Panza, Francesco, Ferrucci, Luigi

    Published in PloS one (11-01-2012)
    “…Frailty is a dynamic age-related condition of increased vulnerability characterized by declines across multiple physiologic systems and associated with an…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Cardiac Rehabilitation in Very Old Adults: Effect of Baseline Functional Capacity on Treatment Effectiveness by Baldasseroni, Samuele, Pratesi, Alessandra, Francini, Sara, Pallante, Rachele, Barucci, Riccardo, Orso, Francesco, Burgisser, Costanza, Marchionni, Niccolò, Fattirolli, Francesco

    “…Objectives To assess the effect of cardiac rehabilitation (CR) and identify predictors of changes in functional capacity with CR in a consecutive series of…”
    Get full text
    Journal Article